Molecules / Vildagliptin

Vildagliptin API manufacturers

CAS 274901-16-5 ATC A10BH02 · DPP-4 inhibitors Updated 9 July 2026
34
manufacturers with an active filing 17 of them hold a US DMF or a CEP
$101.47
median export price per kg $70.00 to $249.83 · 45 exporters · 2025
23
shortage records on file across 4 countries
795
finished-dose makers across 52 regulators
Showing 20 of 34 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Biocon

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for vildagliptin, filing since 2023. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
29 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

Lee Pharma

India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for vildagliptin, filing since 2022. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 6 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
6 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Exemed Pharmaceuticals

India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for vildagliptin, filing since 2023. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · VAI
GMP recognised in
6 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Mankind Pharma

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for vildagliptin, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 14 markets.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
14 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Jiangxi Synergy Pharmaceutical

China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for vildagliptin, filing since 2017. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Glenmark Pharmaceuticals s.r.o

Czech Republic
Makes the APIFinished dose

Registered with SFDA (Saudi Arabia) for vildagliptin. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 40 markets.

US DMF
None on file
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
40 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
07

Viwit Pharmaceutical

China
Makes the API

Holds one active US DMF for vildagliptin, filing since 2019. Its 2024 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
08

MSN Pharmachem

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for vildagliptin, filing since 2013. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
2 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
09

Honour Lab

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for vildagliptin, filing since 2022. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2019 · VAI
GMP recognised in
2 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
10

Innovare Labs

India
Makes the API

Holds one active US DMF for vildagliptin, filing since 2020. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
11

Harman Finochem

India
Makes the API

Registered with SFDA (Saudi Arabia) for vildagliptin. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 3 markets.

US DMF
None on file
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
3 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
12

Alembic Pharmaceuticals

India
Makes the API

Registered with SFDA (Saudi Arabia) for vildagliptin. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.

US DMF
None on file
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
18 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
13

Medichem

Spain
Makes the API

Registered with SFDA (Saudi Arabia) for vildagliptin. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 7 markets.

US DMF
None on file
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
7 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
14

Optimus Drugs

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for vildagliptin, filing since 2024. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
15

Jubilant Biosys

India
Makes the API

Holds 2 active US DMFs for vildagliptin, filing since 2018. Its 2022 FDA inspection closed as VAI.

US DMF
2 active
CEP
None on file
Last FDA inspection
2022 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
16

Linhai Tianyu Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for vildagliptin, filing since 2024. Its 2023 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
18

Fuxin Long Rui Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for vildagliptin, filing since 2018. Its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile

31 more manufacturers hold filings for vildagliptin

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Mankind PharmaJiangxi Synergy PharmaceuticalGlenmark Pharmaceuticals s.r.oViwit PharmaceuticalMSN PharmachemHonour LabInnovare LabsHarman FinochemAlembic PharmaceuticalsMedichemOptimus DrugsJubilant BiosysLinhai Tianyu PharmaceuticalChieron Active IngredientsFuxin Long Rui PharmaceuticalBeijing Huikang Boyuan Chemical TechTianjin Minxiang Pharmaceutical
Open the full list with a free account

Contract manufacturers (11)

Morepen Laboratories India CTX Lifesciences India Hikal India Bajaj Healthcare India Viwit Pharmaceutical China Chengda Pharmaceuticals China Corona Remedies India Anfarm Hellas Greece Hunan Jiudian Hongyang Pharmaceutical China Ami Life Sciences India Chemex Global India

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (72)

Novartis Pharma Produktions Germany Hetero India Getz Pharma Pakistan Zentiva, k.s Czech Republic Zydus Lifesciences India Ajanta Pharma India Novartis Switzerland Olpha Latvia Dr. Reddy's Laboratories India Viatris United States MSN Laboratories India Macleods Pharmaceuticals India Micro Labs India Cadila Pharmaceuticals India Hospira United States Torrent Pharmaceuticals India Sandoz Switzerland Siegfried Barbera S.L Spain Towa Pharmaceutical Europe, S.L Spain Cipla India

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators
Price band
Customs export unit values for 2025. These are export values rather than contract prices for regulated-market grade material, which are higher.

Map vildagliptin for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Price history 4 yrs Shortages 23 Finished dose 72 Contract mfrs 11

By country

India 21 China 12

Export price by year

Year Median Exporters
2026 YTD $108.02 17
2025 $101.47 45
2024 $126.74 41
2023 $161.52 44

US dollars per kilogram, customs export unit values.